Home › NDC Lookup › RxCUI directory › RxCUI 1659183

1 ML alirocumab 75 MG/ML Auto-Injector [Praluent] — RxCUI 1659183

RxNorm drug concept · Semantic branded drug
RxCUI 1659183 Semantic branded drug · SBD ● Current RxNorm concept 4 FDA products 10 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1659183
Official name1 ML alirocumab 75 MG/ML Auto-Injector [Praluent]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as1 ML Praluent 75 MG/ML Auto-Injector; Praluent 75 MG in 1 ML Auto-Injector; Praluent 75 MG per 1 ML Auto-Injector
FDA products mapped4
Package NDCs mapped10
Reported Medicaid activity (SDUD)27,746 prescriptions · 42 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Alirocumab Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Praluent is designed to lower your LDL cholesterol — the 'bad' kind that can build up in your arteries. Depending on why it was prescribed, it may be helping you get your cholester...
  • What exactly is Praluent supposed to do for me?
  • You inject Praluent just under the skin — into your thigh, abdomen, or upper arm — using the pre-filled device. It can take up to 20 seconds to inject. If it has been in the fridge...
  • How do I give myself the injection, and does it hurt?
📖 Read our full Alirocumab Injection guide →

🕸️ Concept Web — How 1 ML alirocumab 75 MG/ML Auto-Injector [Praluent... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 1 ML alirocumab 75 MG/ML Auto-Injector [Praluent] RxCUI 1659183

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Alirocumab 1659152
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Praluent 1659157
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Alirocumab Auto-Injector 1659155
    • Alirocumab Injectable Product 1659154
    • Alirocumab Auto-Injector [Praluent] 1659159
    • Praluent Injectable Product 1659160
    • Auto-Injector 1649570
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Alirocumab 75 MG/ML [Praluent] SBDC · 1659178
  • Alirocumab Auto-Injector [Praluent] SBDF · 1659159
  • Praluent Injectable Product SBDG · 1659160
  • Praluent BN · 1659157

📦 FDA Products & Package NDCs

4 products · 10 package NDCs
10 package NDCs map to RxCUI 1659183 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00024-5901-00 1 SYRINGE, GLASS in 1 CARTON (0024-5901-00) / 1 mL in 1 SYR... Praluent Sanofi-Aventis U.S. LLC 2015-07-24
00024-5901-01 1 SYRINGE, GLASS in 1 CARTON (0024-5901-01) / 1 mL in 1 SYR... Praluent Sanofi-Aventis U.S. LLC 2015-07-24
00024-5902-00 1 SYRINGE, GLASS in 1 CARTON (0024-5902-00) / 1 mL in 1 SYR... Praluent Sanofi-Aventis U.S. LLC 2015-07-24
00024-5902-01 1 SYRINGE, GLASS in 1 CARTON (0024-5902-01) / 1 mL in 1 SYR... Praluent Sanofi-Aventis U.S. LLC 2015-07-24
61755-0020-01 1 SYRINGE, GLASS in 1 CARTON (61755-020-01) / 1 mL in 1 SYR... Praluent Regeneron Pharmaceuticals, Inc. 2020-12-01
61755-0020-02 2 SYRINGE, GLASS in 1 CARTON (61755-020-02) / 1 mL in 1 SYR... Praluent Regeneron Pharmaceuticals, Inc. 2020-12-01
61755-0020-04 1 SYRINGE, GLASS in 1 CARTON (61755-020-04) / 1 mL in 1 SYR... Praluent Regeneron Pharmaceuticals, Inc. 2020-12-01
61755-0021-01 1 SYRINGE, GLASS in 1 CARTON (61755-021-01) / 1 mL in 1 SYR... Praluent Regeneron Pharmaceuticals, Inc. 2020-12-01
61755-0021-02 2 SYRINGE, GLASS in 1 CARTON (61755-021-02) / 1 mL in 1 SYR... Praluent Regeneron Pharmaceuticals, Inc. 2020-12-01
61755-0021-04 1 SYRINGE, GLASS in 1 CARTON (61755-021-04) / 1 mL in 1 SYR... Praluent Regeneron Pharmaceuticals, Inc. 2020-12-01
Observed labelers: Regeneron Pharmaceuticals, Inc. (6) · Sanofi-Aventis U.S. LLC (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.